Defining drug-free remission of skin disease in patients with plaque psoriasis
Br J Dermatol
.
2020 Jun;182(6):1484-1487.
doi: 10.1111/bjd.18694.
Epub 2020 Jan 29.
Authors
A W Armstrong
1
,
A Blauvelt
2
,
J J Crowley
3
,
K B Gordon
4
,
G G Krueger
5
,
J G Krueger
6
,
J M Sobell
7
,
B E Strober
8
9
,
B Srivastava
10
,
A Menter
11
Affiliations
1
University of Southern California, Los Angeles, CA, U.S.A.
2
Oregon Medical Research Center, Portland, OR, U.S.A.
3
Bakersfield Dermatology and Skin Cancer Medical Group, Bakersfield, CA, U.S.A.
4
Medical College of Wisconsin, Milwaukee, WI, U.S.A.
5
University of Utah Medical Center, Salt Lake City, UT, U.S.A.
6
Rockefeller University, New York, NY, U.S.A.
7
Tufts University School of Medicine, Boston, MA, U.S.A.
8
Yale University, New Haven, CT, U.S.A.
9
Central Connecticut Dermatology Research, Cromwell, CT, U.S.A.
10
Janssen Scientific Affairs, LLC, Horsham, PA, U.S.A.
11
Baylor Scott & White at Dallas, Dallas, TX, U.S.A.
PMID:
31705649
DOI:
10.1111/bjd.18694
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Humans
Psoriasis* / drug therapy
Remission Induction
Skin Diseases*
Treatment Outcome